How to Submit to Nature Medicine: A Complete Guide

Nature Medicine desk-rejects approximately 85% of all submissions within 1-3 weeks, without external peer review. Understanding why - and what the 15% that survive look like - is more important than any formatting checklist before you submit.

Here's the full picture of what Nature Medicine wants, how their editorial process works, and how to give your manuscript the best realistic chance.

What Nature Medicine Actually Publishes

Nature Medicine's scope is translational medicine - work that sits at the interface of fundamental biology and human disease. The journal wants papers that do two things at once: advance the biological understanding of a disease mechanism and do so in a way that has clear implications for how that disease is diagnosed, treated, or prevented.

This is a narrower scope than it sounds. "Translational" is used loosely in many fields to mean any research with eventual clinical relevance. Nature Medicine uses it to mean something specific: your paper needs to show the mechanism, and that mechanism needs to be demonstrated in human tissue, patient-derived models, or in a clinical context that validates the biological finding.

Basic science studies - even very good ones - that don't have that human-disease connection get desk-rejected at Nature Medicine. They belong in journals like Nature Cell Biology, Nature Immunology, or the Journal of Experimental Medicine. Clinical studies without mechanistic depth belong at NEJM or The Lancet. Nature Medicine sits in between, and that "in between" is the most demanding position to occupy.

Article Types and What Each Requires

Articles are the primary research format. These are full-length papers with original data. The standard length is 3,000-4,000 words of main text, with 6-8 display items (figures/tables). No page limits, but editors use length as a signal of whether work is concisely presented.

Letters (now called "Brief Communications" in some other Nature journals, but still Letters at Nature Medicine) are shorter original research papers covering findings that don't require full-length presentation. 1,500-word main text, typically 3 display items. These are appropriate for discrete mechanistic findings or focused clinical observations that complete a story without needing extensive background.

Review Articles and Perspectives are primarily commissioned. If you haven't been invited, a brief presubmission inquiry to the editorial office is worth doing before writing a full review. Cold submission of unsolicited reviews has a very high desk rejection rate.

Clinical Trial results can be published as Articles if they include mechanistic depth. Pure efficacy/safety reporting without biological endpoints is typically redirected toward NEJM, Lancet, or JAMA.

The Cover Letter: More Important Here Than at Most Journals

Nature Medicine editors read the cover letter before they read the manuscript. It's the first filter.

A strong Nature Medicine cover letter does three things:

States the central finding in plain language. Not "we investigated the role of X in Y." The actual finding: "We show that [mechanism] drives [disease outcome] via [pathway], and that [intervention] targeting this pathway reverses disease progression in a patient-derived model." One sentence, one claim.

Explains why it belongs in Nature Medicine specifically. This means articulating the translational impact: what does this finding change about how we understand, diagnose, or treat the disease? Why is this the right journal for this scope, rather than Nature Immunology or JCI?

Situates the work against the most relevant recent literature. 2-3 sentences on what was known, what the key gap was, and how your paper fills it. Editors are checking whether your novelty claim is accurate.

Common cover letter failures: too much background, burying the finding in the third paragraph, using vague language like "insights into" or "may contribute to," and failing to explain the disease relevance directly.

What Gets Desk-Rejected at Nature Medicine

The 85% desk rejection rate sounds harsh. The reasoning is fairly consistent:

Wrong scope. Basic science without human disease connection. Clinical studies without mechanistic depth. Technology papers without disease application. Even excellent papers in the wrong scope get rejected.

Novelty threshold not met. Nature Medicine expects to publish work that changes how the field thinks about a disease mechanism. Confirming known biology in a new model system, adding an additional patient cohort to existing findings, or extending a mechanism to a related disease process - these are appropriate for Nature Communications or specialty journals, not Nature Medicine.

Translational story is incomplete. A strong mouse model study without any human tissue validation, or a human tissue finding without any mechanistic functional data. Nature Medicine typically wants both.

Too narrow a disease scope. Work with implications for a specific patient subpopulation or a rare disease process can be excellent but doesn't always meet Nature Medicine's threshold for broad clinical relevance.

Peer Review at Nature Medicine: What Reviewers Are Looking For

If your paper survives desk review, it goes to 2-3 external reviewers with specific expertise in your disease area and the relevant methods. Nature Medicine reviewers are typically active researchers at the interface of basic and clinical science.

What they're specifically assessing:

Mechanistic rigor. Are the causal claims supported by functional data, or just correlative? Reviewers will flag overreach in interpretation aggressively.

Validation depth. Is the central finding validated across multiple independent systems? A result that holds in one cell line and one mouse model is weaker than one replicated in patient tissue, primary cells, and in vivo.

Clinical relevance. Is the translational connection explicit and direct, or aspirational? "This could potentially inform future therapies" is weaker than "We show that blocking X in patient-derived organoids reverses Y phenotype."

Statistical analysis. Sample sizes, appropriate tests for data type, correction for multiple comparisons, representation of biological replicates vs technical replicates.

Timeline: What to Expect

First decision (desk accept or reject): 1-3 weeks from submission. Nature Medicine is relatively fast at desk review.

If sent for external review, expect 6-12 weeks to a post-review decision.

If a revision is requested, you typically have 3-6 months. Revised manuscripts are usually returned to the same reviewers.

Total time from initial submission to publication (including a typical revision cycle): 6-18 months. Accepted papers move quickly through production - typically 2-4 weeks from acceptance to online publication.

Practical Submission Checklist

Before submitting to Nature Medicine, verify:

• The central finding is mechanistic and demonstrated in a human-relevant system (patient tissue, patient-derived cells, clinical validation)
• The paper can't be more accurately described as basic science or pure clinical research
• You can write one clear sentence stating the finding and its clinical implication
• The novelty claim holds against papers published in the last 24 months, not just the last 5 years
• All figures are in the required format (300 dpi minimum, panel labels in 8pt font minimum)
• Author contributions are clearly delineated
• Competing interests are declared explicitly

The Bottom Line

Nature Medicine's editorial standard can be summarized in one sentence: the finding must be mechanistically sound AND clinically meaningful, with both components demonstrated directly in the paper. Papers that are mechanistically excellent but not clinically grounded, or clinically interesting but not mechanistically deep, get desk-rejected.

If your paper passes that test, the submission process is standard: strong cover letter emphasizing the translational finding, concise main text, well-validated mechanistic story, and honest assessment of limitations. The editorial team is looking for reasons to send the paper forward, not reasons to reject it - if the science is there and the story is clear, it will get reviewed.

Frequently Asked Questions

What is Nature Medicine's acceptance rate?

Approximately 7-9% of all submissions are published. Around 85% are desk-rejected before peer review. Of papers that reach external review, roughly 50-60% are eventually accepted after revision.

Should I do a presubmission inquiry before submitting to Nature Medicine?

It's optional but can save time. Nature Medicine accepts brief presubmission inquiries (typically a 1-page summary of the main finding and translational significance). Editors usually respond within 1-2 weeks with a yes or no on whether the topic is in scope. Worth doing if you have any uncertainty about whether the work fits.

Does Nature Medicine require open access?

Nature Medicine offers both subscription publishing (no APC) and open access (APC of approximately £9,670 / $11,690). Open access isn't mandatory, but many funders with OA mandates (Wellcome Trust, NIH OA policy) require it. Check your funder requirements before submission.

Can I submit work that's posted as a preprint on bioRxiv?

Yes. Nature Medicine accepts submissions of work that has been posted to bioRxiv or medRxiv. They do not consider preprint posting as prior publication.

How important is clinical data for a Nature Medicine paper?

Very important. The translational bridge is the core of Nature Medicine's scope. Papers that are excellent basic science but lack validation in human tissue, patient-derived models, or clinical cohorts are typically desk-rejected or redirected to Nature family specialty journals with a more basic-science orientation.

Sources

• Nature Medicine author guidelines - nature.com/nm/submission-guidelines
• Nature Medicine about the journal - nature.com/nm/about
• Clarivate Journal Citation Reports 2024

See also

• Nature Medicine journal profile
• Is Nature Medicine a good journal?
• Nature Medicine impact factor explained
• How to write a cover letter for journal submission
• Why papers get desk rejected